BioInvent International AB (publ) (LON:0H22)
31.45
+1.50 (5.01%)
At close: Nov 20, 2025
BioInvent International AB Employees
BioInvent International AB had 114 employees as of December 31, 2024. The number of employees increased by 3 or 2.70% compared to the previous year.
Employees
114
Change (1Y)
3
Growth (1Y)
2.70%
Revenue / Employee
155.90K GBP
Profits / Employee
-206.25K GBP
Market Cap
162.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114 | 3 | 2.70% |
| Dec 31, 2023 | 111 | 17 | 18.09% |
| Dec 31, 2022 | 94 | 10 | 11.90% |
| Dec 31, 2021 | 84 | 12 | 16.67% |
| Dec 31, 2020 | 72 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |